[sk11001]

I don't think the title of the post is accurate, at least not based on the link.

> Here, we present data from a proof-of-concept study on 30 individuals with obstructive sleep apnea and obesity who were randomized to a GLP-1 therapy-based weight loss regimen, continuous positive airway pressure, or a combination of both for 24 weeks.

They compared weight loss medication to a sleep apnea treatment and the weight loss medication group lost fat... which happens when your appetite is suppressed and you eat less - you lose some muscle and some fat, some of the fat you lose is visceral, some isn't.

[pizza]

They note that their discovery relating VAT activity increase to weight loss wasn't the original focus of their study, so they hadn't prepared an additional weight loss control group - I think they leave open both appetite suppression and metabolism increase as possible factors - "individuals with lower VAT metabolic activity may benefit most from the dual impact of GLP-1 on reduction of energy intake and increased metabolic activity"